| Log in

Opportunistically will go for acquisitions, strategically no: SRL CEO Sanjeev Vashishta

08 October, 2016

SRL, India’s largest diagnostics chain, will go for acquisitions if it finds assets for value even as it believes that it is by and large done with its expansion in the country. In an interview with VCCircle, the company’s CEO Sanjeev Vashishta said, “Opportunistically yes but strategically no.”

Vashishta also said that the challenge is not so much from the growth of the PE-backed regional players as the diagnostics industry is big enough to accommodate them. What is worrying, Vashishta said, is whether the companies are following the essential quality standards so that consumers are not taken for a ride.

Like this video? Sign up for our daily newsletter to get our top reports & videos.


Leave Your Comment
How former SRL CEO Sanjeev Vashishta aims to build Mankind's diagnostics biz

How former SRL CEO Sanjeev Vashishta aims to build Mankind’s diagnostics biz

Joseph Rai 9 months ago
Pathkind Diagnostics Pvt. Ltd will bet on an organic growth strategy and tap...
Mankind Pharma picks industry veteran for diagnostics biz float

Mankind Pharma picks industry veteran for diagnostics biz float

Joseph Rai 10 months ago
Drugmaker Mankind Pharma Ltd is entering the diagnostics business and has picked...
Diagnostics biz can easily sustain 16-18% annual growth in long term: SRL CEO

Diagnostics biz can easily sustain 16-18% annual growth in long term: SRL CEO

Joseph Rai 1 year ago
In August, Fortis Healthcare said its board has approved a restructuring plan...
No Comments

Opportunistically will go for acquisitions, strategically no: SRL CEO Sanjeev Vashishta

Powered by WordPress.com VIP